Effects of adrenomedullin on systolic and diastolic myocardial function

Peptides

Volumn 30, Issue 4, 2009, Pages 796-802

  Fontes Sousa, Ana Patrícia ^a   Pires, Ana Luísa ^a   Carneiro, Catarina Santos ^a   Brás Silva, Carmen ^a   Leite Moreira, Adelino F ^a  

^a University of Porto   (Portugal)

Author keywords

Adrenomedullin; Inotropism; Lusitropism; Myocardial stiffness

Indexed keywords

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; KT 5720;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; HEART FUNCTION; MUSCLE LENGTH; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADRENOMEDULLIN; ANIMALS; DIASTOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; MALE; RABBITS; SYSTOLE;

ORYCTOLAGUS CUNICULUS;

EID: 62749178503     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.12.011     Document Type: Article

References (63)

1. Beltowski J., and Jamroz A. Adrenomedullin-what do we know 10 years since its discovery?. Pol J Pharmacol 56 (2004) 5-27
2. Bisping E., Tenderich G., Barckhausen P., Stumme B., Bruns S., von Lewinski D., et al. Atrial myocardium is the predominant inotropic target of adrenomedullin in the human heart. Am J Physiol 293 (2007) H3001-H3007
3. Boussery K., Delaey C., and Van de Voorde J. Influence of adrenomedullin on tone of isolated bovine retinal arteries. Invest Ophthalmol Vis Sci 45 (2004) 552-559
4. Bras-Silva C., Fontes-Sousa A.P., Moura C., Areias J.C., and Leite-Moreira A.F. Impaired response to ET(B) receptor stimulation in heart failure: functional evidence of endocardial endothelial dysfunction?. Exp Biol Med (Maywood, NJ) 231 (2006) 893-898
5. Bras-Silva C., and Leite-Moreira A.F. Obligatory role of the endocardial endothelium in the increase of myocardial distensibility induced by endothelin-1. Exp Biol Med (Maywood, NJ) 231 (2006) 876-881
6. Brutsaert D.L., De Keulenaer G.W., Fransen P., Mohan P., Kaluza G.L., Andries L.J., et al. The cardiac endothelium: functional morphology, development, and physiology. Prog Cardiovasc Dis 39 (1996) 239-262
7. Brutsaert D.L., Meulemans A.L., Sipido K.R., and Sys S.U. Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res 62 (1988) 358-366
8. Buhlmann N., Leuthauser K., Muff R., Fischer J.A., and Born W. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology 140 (1999) 2883-2890
9. Castro-Chaves P., Pimentel-Nunes P., Fontes-Carvalho R., Soares J.B., Martins J., and Leite-Moreira A.F. Angiotensin II-induced increase in myocardial distensibility is modulated by the endocardial endothelium, endothelin-1 and nitric oxide. J Am Coll Cardiol 49 53A-A Suppl. (2007)
10. De Matteo R., and May C.N. Direct coronary vasodilator action of adrenomedullin is mediated by nitric oxide. Brit J Pharmacol 140 (2003) 1414-1420
11. Drexler H., Hayoz D., Munzel T., Hornig B., Just H., Brunner H.R., et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 69 (1992) 1596-1601
12. Eguchi S., Hirata Y., Iwasaki H., Sato K., Watanabe T.X., Inui T., et al. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 135 (1994) 2454-2458
13. Eto T., Kato J., and Kitamura K. Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regul Peptides 112 (2003) 61-69
14. Feng C.J., Kang B., Kaye A.D., Kadowitz P.J., and Nossaman B.D. l-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat. Life Sci 55 (1994) PL433-PL438
15. Fontes-Sousa A.P., Brás-Silva C., Pires A.L., Monteiro-Sousa D., and Leite-Moreira A.F. Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling. Naunyn Schmiedebergs Arch Pharmacol 376 1-2 (2007) 107-115
16. Hay D.L., Conner A.C., Howitt S.G., Smith D.M., and Poyner D.R. The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors. J Mol Neurosci 22 (2004) 105-113
17. Hay D.L., Howitt S.G., Conner A.C., Schindler M., Smith D.M., and Poyner D.R. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin 22-52, CGRP 8-37 and BIBN4096BS. Brit J Pharmacol 140 (2003) 477-486
18. Hay D.L., and Smith D.M. Adrenomedullin receptors: molecular identity and function. Peptides 22 (2001) 1753-1763
19. Hyvelin J.M., Shan Q., and Bourreau J.P. Adrenomedullin: a cardiac depressant factor in septic shock. J Cardiac Surg 17 (2002) 328-335
20. Ihara T., Ikeda U., Tate Y., Ishibashi S., and Shimada K. Positive inotropic effects of adrenomedullin on rat papillary muscle. Eur J Pharmacol 390 (2000) 167-172
21. Ikeda U., Kanbe T., Kawahara Y., Yokoyama M., and Shimada K. Adrenomedullin augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. Circulation 94 (1996) 2560-2565
22. Ikenouchi H., Kangawa K., Matsuo H., and Hirata Y. Negative inotropic effect of adrenomedullin in isolated adult rabbit cardiac ventricular myocytes. Circulation 95 (1997) 2318-2324
23. Ishimitsu T., Nishikimi T., Saito Y., Kitamura K., Eto T., Kangawa K., et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 94 (1994) 2158-2161
24. Jougasaki M., Wei C.M., McKinley L.J., and Burnett Jr. J.C. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 92 (1995) 286-289
25. Kapas S., Catt K.J., and Clark A.J. Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J Biol Chem 270 (1995) 25344-25347
26. Kelly R.A., Balligand J.L., and Smith T.W. Nitric oxide and cardiac function. Circ Res 79 (1996) 363-380
27. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192 (1993) 553-560
28. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., and Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 194 (1993) 720-725
29. Lainchbury J.G., Meyer D.M., Jougasaki M., Burnett Jr. J.C., and Redfield M.M. Effects of adrenomedullin on load and myocardial performance in normal and heart-failure dogs. Am J Physiol 279 (2000) H1000-H1006
30. Leite-Moreira A.F. Current perspectives in diastolic dysfunction and diastolic heart failure. Heart (Brit Cardiac Soc) 92 (2006) 712-718
31. Leite-Moreira A.F., Bras-Silva C., Pedrosa C.A., and Rocha-Sousa A.A. ET-1 increases distensibility of acutely loaded myocardium: a novel ETA and Na+/H+ exchanger-mediated effect. Am J Physiol 284 (2003) H1332-H1339
32. Leite-Moreira A.F., Castro-Chaves P., Pimentel-Nunes P., Lima-Carneiro A., Guerra M.S., Soares J.B., et al. Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+ exchanger-mediated effect. Brit J Pharmacol 147 (2006) 690-697
33. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393 (1998) 333-339
34. Mittra S., and Bourreau J.P. Gs and Gi coupling of adrenomedullin in adult rat ventricular myocytes. Am J Physiol 290 (2006) H1842-H1847
35. Mittra S., Hyvelin J.M., Shan Q., Tang F., and Bourreau J.P. Role of cyclooxygenase in ventricular effects of adrenomedullin: is adrenomedullin a double-edged sword in sepsis?. Am J Physiol 286 (2004) H1034-H1042
36. Miyao Y., Nishikimi T., Goto Y., Miyazaki S., Daikoku S., Morii I., et al. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart (Brit Cardiac Soc) 79 (1998) 39-44
37. Morgan J.P. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 325 (1991) 625-632
38. Mukherjee R., Multani M.M., Sample J.A., Dowdy K.B., Zellner J.L., Hoover D.B., et al. Effects of adrenomedullin on human myocyte contractile function and beta-adrenergic response. J Cardiovasc Pharmacol Therap 7 (2002) 235-240
39. Nagaya N., Satoh T., Nishikimi T., Uematsu M., Furuichi S., Sakamaki F., et al. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 101 (2000) 498-503
40. Nicholls M.G., Charles C.J., Lainchbury J.G., Lewis L.K., Rademaker M.T., Richards A.M., et al. Adrenomedullin in heart failure. Hypertens Res 26 Suppl. (2003) S135-S140
41. Nishikimi T., Horio T., Yoshihara F., Nagaya N., Matsuo H., and Kangawa K. Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes. Eur J Pharmacol 353 (1998) 337-344
42. Nishikimi T., Yoshihara F., Mori Y., Kangawa K., and Matsuoka H. Cardioprotective effect of adrenomedullin in heart failure. Hypertens Res 26 Suppl. (2003) S121-S127
43. Nishimatsu H., Suzuki E., Nagata D., Moriyama N., Satonaka H., Walsh K., et al. Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta. Circ Res 89 (2001) 63-70
44. Oie E., Vinge L.E., Yndestad A., Sandberg C., Grogaard H.K., and Attramadal H. Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats. Circulation 101 (2000) 415-422
45. Oya H., Nagaya N., Furuichi S., Nishikimi T., Ueno K., Nakanishi N., et al. Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure. Am J Cardiol 86 (2000) 94-98
46. Pan C.S., Jin S.J., Cao C.Q., Zhao J., Zhang J., Wang X., et al. The myocardial response to adrenomedullin involves increased cAMP generation as well as augmented Akt phosphorylation. Peptides 28 (2007) 900-909
47. Parkes D.G. Cardiovascular actions of adrenomedullin in conscious sheep. Am J Physiol 268 (1995) H2574-H2578
48. Paulus W.J., and Shah A.M. NO and cardiac diastolic function. Cardiovasc Res 43 (1999) 595-606
49. Paulus W.J., Tschope C., Sanderson J.E., Rusconi C., Flachskampf F.A., Rademakers F.E., et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J (2007)
50. Paulus W.J., Vantrimpont P.J., and Shah A.M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89 (1994) 2070-2078
51. Paulus W.J., Vantrimpont P.J., and Shah A.M. Paracrine coronary endothelial control of left ventricular function in humans. Circulation 92 (1995) 2119-2126
52. Perret M., Broussard H., LeGros T., Burns A., Chang J.K., Summer W., et al. The effect of adrenomedullin on the isolated heart. Life Sci 53 (1993) PL377-PL379
53. Rademaker M.T., Charles C.J., Lewis L.K., Yandle T.G., Cooper G.J., Coy D.H., et al. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation 96 (1997) 1983-1990
54. Saetrum Opgaard O., de Vries R., Tom B., Edvinsson L., and Saxena P.R. Positive inotropy of calcitonin gene-related peptide and amylin on porcine isolated myocardium. Eur J Pharmacol 385 (1999) 147-154
55. Saetrum Opgaard O., Hasbak P., de Vries R., Saxena P.R., and Edvinsson L. Positive inotropy mediated via CGRP receptors in isolated human myocardial trabeculae. Eur J Pharmacol 397 (2000) 373-382
56. Sexton P.M., Albiston A., Morfis M., and Tilakaratne N. Receptor activity modifying proteins. Cell Signal 13 (2001) 73-83
57. Shah A.M., and MacCarthy P.A. Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Therap 86 (2000) 49-86
58. 2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 270 (1995) 4412-4417
59. Stangl V., Dschietzig T., Bramlage P., Boye P., Kinkel H.T., Staudt A., et al. Adrenomedullin and myocardial contractility in the rat. Eur J Pharmacol 408 (2000) 83-89
60. Szokodi I., Kinnunen P., Tavi P., Weckstrom M., Toth M., and Ruskoaho H. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation 97 (1998) 1062-1070
61. Terata K., Miura H., Liu Y., Loberiza F., and Gutterman D.D. Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K(+) channels. Am J Physiol 279 (2000) H2620-H2626
62. Udawela M., Hay D.L., and Sexton P.M. The receptor activity modifying protein family of G protein coupled receptor accessory proteins. Semin Cell Develop Biol 15 (2004) 299-308
63. Zimmermann U., Fischer J.A., and Muff R. Adrenomedullin and calcitonin gene-related peptide interact with the same receptor in cultured human neuroblastoma SK-N-MC cells. Peptides 16 (1995) 421-424